Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation

E-ISSN： 1873-4286|16|30|3339-3351

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.30, 2010-10, pp. : 3339-3351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3372-3378

Bentham Science Publishers

Access to resources Recommend Favorite

Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3352-3360

Bentham Science Publishers

Access to resources Recommend Favorite

Proof of principle: antiretroviral drugs can prevent sexual transmission of HIV-1

By Wainberg Mark A Field Hugh J

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 549-551

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy

By Vidal Francesc Domingo Pere Viladés Consuelo Peraire Joaquim Arnedo Mireia Alcamí José Leal Manuel Villarroya Francesc Gatell Josep Ma

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1365-1382

Informa Healthcare

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite